The role of histone methylase and demethylase in antitumor immunity: A new direction for immunotherapy

Front Immunol. 2023 Jan 11:13:1099892. doi: 10.3389/fimmu.2022.1099892. eCollection 2022.

Abstract

Epigenetic modifications may alter the proliferation and differentiation of normal cells, leading to malignant transformation. They can also affect normal stimulation, activation, and abnormal function of immune cells in the tissue microenvironment. Histone methylation, coordinated by histone methylase and histone demethylase to stabilize transcription levels in the promoter area, is one of the most common types of epigenetic alteration, which gained increasing interest. It can modify gene transcription through chromatin structure and affect cell fate, at the transcriptome or protein level. According to recent research, histone methylation modification can regulate tumor and immune cells affecting anti-tumor immune response. Consequently, it is critical to have a thorough grasp of the role of methylation function in cancer treatment. In this review, we discussed recent data on the mechanisms of histone methylation on factors associated with immune resistance of tumor cells and regulation of immune cell function.

Keywords: antitumor immunity; epigenetic modification; histone methylation; immunotherapy; tumor.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Epigenesis, Genetic*
  • Histone Methyltransferases / metabolism
  • Histones* / metabolism
  • Immunotherapy
  • Methylation

Substances

  • Histones
  • Histone Methyltransferases

Grants and funding

This work was supported in part by the National Natural Science Foundation of China (81360366,81302169); Guizhou Science and Technology Plan Project (Foundation (2019) 1198, Foundation Foundation [2020] 1Z064).